Consolidated Portfolio Review Corp Grows Holdings in BlackRock Health Sciences Trust $BME

Consolidated Portfolio Review Corp increased its stake in shares of BlackRock Health Sciences Trust (NYSE:BME) by 40.2% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 54,522 shares of the company’s stock after purchasing an additional 15,643 shares during the period. Consolidated Portfolio Review Corp’s holdings in BlackRock Health Sciences Trust were worth $2,030,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Legacy Wealth Managment LLC ID purchased a new stake in BlackRock Health Sciences Trust in the second quarter valued at approximately $55,000. SOA Wealth Advisors LLC. boosted its position in shares of BlackRock Health Sciences Trust by 20.3% during the third quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock worth $103,000 after buying an additional 469 shares during the period. Geneos Wealth Management Inc. grew its stake in shares of BlackRock Health Sciences Trust by 200.0% in the second quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock valued at $179,000 after buying an additional 3,266 shares in the last quarter. Sage Investment Counsel LLC purchased a new stake in shares of BlackRock Health Sciences Trust in the 3rd quarter valued at $201,000. Finally, Truist Financial Corp acquired a new position in BlackRock Health Sciences Trust during the 3rd quarter worth about $205,000.

BlackRock Health Sciences Trust Stock Performance

Shares of BlackRock Health Sciences Trust stock opened at $41.19 on Friday. The business has a 50-day moving average of $41.88 and a 200 day moving average of $39.68. BlackRock Health Sciences Trust has a 12 month low of $34.18 and a 12 month high of $42.74.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be paid a $0.2621 dividend. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) annualized dividend and a dividend yield of 7.6%.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.